Financials

  • Market Capitalization 1.97 B
  • Employee 367
  • Founded 2016
  • CEO Marianne De Backer
  • Website www.vir.bio
  • Headquarter Delaware, United States
  • FIGI BBG00H2QQ8T5
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.48
市销率
5.42

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
1980
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
34.21 USD+1.57%+1.09%+11.14%-21.16%2.04 B USD
2001
STOK
Stoke Therapeutics, Inc. - Common Stock
30.89 USD-0.99%-6.99%+7.93%+61.05%1.99 B USD
2028
NBTX
Nanobiotix S.A. - ADSs
39.29 USD-3.32%-4.94%+4.58%+329.87%1.90 B USD
2030
IMCR
Immunocore Holdings plc - American Depositary Shares
36.86 USD+1.49%-1.05%+9.05%+10.10%1.90 B USD

新闻